TUhjnbcbe - 2021/5/22 12:05:00
Prognosticbenefitsofprioramiodaroneorβ-blockerusebeforetheonsetofventriculararrhythmiawithhemodynamiccollapseHeartandVesselsOriginalArticleEarlyRecent,Mar15,./s---2本文由“天纳”临床学术信息人工智能系统自动翻译点击文末“阅读原文”下载本文PDFAlthoughantiarrhythmicdrugshavelongbeenusedforthesuppressionofvarioustypesofarrhythmias,theirpriorusebeforetheonsetofventriculararrhythmiawithhemodynamiccollapseandtheeffectonprognosisisnotwellknown.DatafromconsecutivepatientswithcardiovascularshockintheJapaneseCirculationSociety’sShockRegistrywereanalyzed.Eighty-fourcasesofventriculararrhythmia-inducedshockandROSC(returnofspontaneouscirculation)weredividedintotheprioramiodaroneorβ-blockersusegroup(Aβgroup,n?=?27)andthenon-amiodaroneandnon-β-blockersusegroup(non-Aβgroup;n?=?57)basedontreatmentbeforetheonsetofthosearrhythmias.Clinicalout